M Arnold Munnich

Title: M Arnold Munnich: Innovator in Genetic Treatments

Introduction

M Arnold Munnich is a prominent inventor based in Paris, France. He has made significant contributions to the field of genetic research, particularly in the treatment of inherited retinal diseases. With a total of 5 patents, Munnich's work has the potential to impact many lives.

Latest Patents

Munnich's latest patents focus on innovative methods for treating Leber congenital amaurosis. One of his notable inventions involves a method for treating this condition in patients harboring the mutation c.2991+1655 A>G in the CEP290 gene. The method comprises administering at least one antisense oligonucleotide that is complementary to the nucleic acid sequence necessary for preventing splicing of the cryptic exon inserted into the mutant c.2991+1655 A>G CEP290 mRNA. This groundbreaking approach aims to provide a therapeutic solution for patients affected by this genetic disorder.

Career Highlights

Throughout his career, Munnich has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His dedication to research and innovation has positioned him as a leader in the field of genetic therapies.

Collaborations

Munnich has collaborated with notable colleagues, including Jean-Michel Rozet and Antoine Kichler. These partnerships have furthered his research and contributed to the advancement of genetic treatment methodologies.

Conclusion

M Arnold Munnich's contributions to genetic research and his innovative patents in the treatment of Leber congenital amaurosis highlight his role as a significant figure in the field. His work continues to inspire advancements in medical science and offers hope to those affected by genetic disorders.